Short answer
Humana (HUM) filed its Q3 2025 10-Q quarterly report on Nov 5, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $32.6B (up 11.1% year over year) with net income of $195M.
Q3 2025 key financials · XBRL
- Revenue
- $32.6B
- +11.1% YoY · +0.8% QoQ
- Net income
- $195M
- −59.4% YoY · −64.2% QoQ
- Operating margin
- 1.2%
- EPS (diluted)
- $1.62
- −59.3% YoY · −64.1% QoQ
Source: XBRL data from the Humana (HUM) Q3 2025 10-Q on SEC EDGAR. USD.
Humana Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $32.6B Q3 2025, up 11.1% YoY from $29.4B; 9M revenue $97.1B up 9.7% YoY from $88.5B
- Operating margin declined: income from operations $3.5B Q3 2025 vs $3.1B Q3 2024 (13.1% increase YoY but 45.1% decrease in 9M); benefit ratio 91.1% vs 89.9% Q3, operating cost ratio 12.6% vs 11.5% Q3
- Best segment: Insurance segment income from operations $2.6B 9M 2025, up 33.9% YoY; Worst: CenterWell income from operations $305M Q3 2025, down 20.2% YoY
- Cash and cash equivalents $5.4B at Sept 30, 2025, up from $2.2B at Dec 31, 2024; Operating cash flow $2.6B 9M 2025, down from $3.5B 9M 2024; issued $1.5B senior notes, repurchased $200M senior notes, repurchased $109M common shares
- Outlook: Expects continued charges for workforce and consulting initiatives; facing regulatory risks from evolving healthcare laws; plans to maintain capital to fund growth and regulatory needs
Risk Factors
- Section 'risk_factors' was empty or not found.
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Humana quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.